Loading...
Opthea Limited
OPT•NASDAQ
HealthcareBiotechnology
$3.41
$0.05(1.49%)
Opthea Limited (OPT) Financial Performance & Statements
Review Opthea Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-22.65%
↓ 22.65%
Operating Income Growth
14.14%
↑ 14.14%
Net Income Growth
-3.95%
↓ 3.95%
Operating Cash Flow Growth
10.20%
↑ 10.20%
Operating Margin
-328804.39%
↓ 328804.39%
Gross Margin
-117.85%
↓ 117.85%
Net Profit Margin
-280147.65%
↓ 280147.65%
ROE
259.61%
↑ 259.61%
ROIC
-689.56%
↓ 689.56%
Opthea Limited (OPT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Opthea Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $89389.00 | $93181.00 | $83337.00 | $77793.00 |
| Cost of Revenue | $222911.00 | $78383.00 | $127926.00 | $119893.00 |
| Gross Profit | -$133522.00 | $14798.00 | -$44589.00 | -$42100.00 |
| Gross Profit Ratio | -$1.49 | $0.16 | -$0.54 | -$0.54 |
| R&D Expenses | $139.38M | $129.65M | $89.84M | $91.72M |
| SG&A Expenses | $9.81M | $14.25M | $15.79M | $26.24M |
| Operating Expenses | $287.48M | $143.90M | $105.63M | $117.95M |
| Total Costs & Expenses | $287.70M | $143.97M | $105.70M | $117.95M |
| Interest Income | $2.79M | $2.76M | $3.14M | $1.65M |
| Interest Expense | $30.03M | $16.09M | $14.78M | $5.20M |
| Depreciation & Amortization | $14646.00 | $78383.00 | $62338.00 | $10730.00 |
| EBITDA | -$147.07M | -$138.97M | -$105.55M | -$112.96M |
| EBITDA Ratio | -$1645.23 | -$1491.39 | -$1266.56 | -$1515.26 |
| Operating Income | -$287.61M | -$143.88M | -$105.61M | -$117.88M |
| Operating Income Ratio | -$3217.52 | -$1544.10 | -$1267.31 | -$1515.26 |
| Other Income/Expenses (Net) | $95.07M | -$11.26M | $3.03M | -$281937.00 |
| Income Before Tax | -$192.54M | -$155.14M | -$102.59M | -$118.16M |
| Income Before Tax Ratio | -$2154.00 | -$1664.92 | -$1231.003 | -$1518.88 |
| Income Tax Expense | -$6.65M | -$7.72M | -$5.75M | -$3.05M |
| Net Income | -$185.99M | -$147.42M | -$96.84M | -$115.11M |
| Net Income Ratio | -$2080.63 | -$1582.05 | -$1162.06 | -$1479.64 |
| EPS | -$0.27 | -$0.25 | -$0.20 | -$0.23 |
| Diluted EPS | -$0.27 | -$0.25 | -$0.20 | -$0.23 |
| Weighted Avg Shares Outstanding | $683.76M | $592.64M | $495.57M | $495.31M |
| Weighted Avg Shares Outstanding (Diluted) | $683.77M | $592.64M | $495.57M | $495.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan